Author:
Collins M.,Michot J.M.,Danlos F.X.,Mussini C.,Soularue E.,Mateus C.,Loirat D.,Buisson A.,Rosa I.,Lambotte O.,Laghouati S.,Chaput N.,Coutzac C.,Voisin A.L.,Soria J.C.,Marabelle A.,Champiat S.,Robert C.,Carbonnel F.
Funder
Institut National de la Santé et de la Recherche Médicale
Reference24 articles.
1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010
2. Nivolumab plus ipilimumab in advanced melanoma;Wolchok;N Engl J Med,2013
3. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011
4. Cancer Immunotherapy with anti-CTLA-4 monoclonal antibodies induces an inflammatory bowel disease;Marthey;J Crohns Colitis,2016
5. Systematic review: colitis associated with anti-CTLA-4 therapy;Gupta;Aliment Pharmacol Ther,2015
Cited by
126 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献